Related references
Note: Only part of the references are listed.
Article
Gastroenterology & Hepatology
Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone
BA Neuschwander-Tetri et al.
HEPATOLOGY (2003)
Share Paper
